SJG-136 in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of SJG-136 in treating patients
with advanced solid tumors. Drugs used in chemotherapy, such as SJG-136, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing.